URG4 expression is a novel prognostic factor for the progression of nasopharyngeal carcinoma and overall survival of patient.

about

URG4 expression is a novel prognostic factor for the progression of nasopharyngeal carcinoma and overall survival of patient.

Item

http://www.wikidata.org/entity/Q41972636

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

URG4 expression is a novel pro ...... d overall survival of patient.

@en

type

Item

label

URG4 expression is a novel pro ...... d overall survival of patient.

@en

prefLabel

URG4 expression is a novel pro ...... d overall survival of patient.

@en

P1476

URG4 expression is a novel pro ...... d overall survival of patient.

@en

P2093

Benfu He

http://www.w3.org/2001/XMLSchema#string

Chen Zeng

http://www.w3.org/2001/XMLSchema#string

Guodong Yu

http://www.w3.org/2001/XMLSchema#string

Qingxiang Meng

http://www.w3.org/2001/XMLSchema#string

Shanshan Zhang

http://www.w3.org/2001/XMLSchema#string

Tian Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

AKT/PKB signaling: navigating downstream

Enhanced cell survival of gastric cancer cells by a novel gene URG4

Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival

A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci

Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma

Prognostic significance and therapeutic implications of centromere protein F expression in human nasopharyngeal carcinoma

Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.

Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival.

URG4 overexpression is correlated with cervical cancer progression and poor prognosis in patients with early-stage cervical cancer

Serological identification of URGCP as a potential biomarker for glioma.

P304

3059-3065

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S95476

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27284257

http://www.w3.org/2001/XMLSchema#string

P932

4883802

http://www.w3.org/2001/XMLSchema#string